Aducanumab

June 10, 2021 Rima 0

Aducanumab is recently approved by FDA (7th June 2021) for treatment of Alzheimer’s disease. It is the first of its type and targets progression of […]

Remdesivir

May 1, 2020 Bikash 0

Remdesivir is an investigational anti-viral compound undergoing clinical trials in China, the United states and the United Kingdom as a potential treatment for COVID-19. Today, […]